OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches
Ontario's First Chief Science Officer
Canadian Bioscience Advances Industry Building Solutions
Ontario Bioscience Supports Member Growth
OBIO Launches the Health 2 Business Bridge H2BB Program Improving Access to Business Trained Talent in Ontario’s Health Science Industry
OBIO hosted its Annual Public Meeting with the theme centered on “Bridging the Access to Talent Gap” at Norton Rose Fulbright LLP yesterday. The OBIO Annual Public Meeting provided a platform to highlight OBIO’s accomplishments made in 2016, upcoming initiatives for 2017 and an opportunity to hear from Parliamentary Assistant to the Minister of Economic Development and Growth, Cristina Martins and Members of the OBIO MPP Health Science Caucus, MPP Shafiq Qaadri and MPP Bill Walker, who welcomed networking with over 60 health science industry professionals.
“OBIO’s ongoing dialogue with industry has identified access to industry ready business talent as a challenge for health science companies seeking to scale up and commercialize their technologies.”
Read the Full Press Release HERE
OBIO Announces a Call for Applications for the 2017 Capital Access Advisory Program
AdvaMed Investor Insights
Health Economics in the Medical Device Space
Thoughts from OBIO's own VP of Strategic Finance, Christine Charette, summarizing the topics relevant to startups at the 2016 AdvaMed Conference.
For the PDF article click here
RESI Conference and Digital Medicine Connect at Biopharm America: Part 2
Christine Charette, SVP Strategic Finance, OBIO shares her advice on navigating the Health Science Investor in Part 2 of the Combined Conference Insights on RESI Boston & Digital Medicine Connect at BioPharm America September 13,14,15 2016
For the full PDF of the article click here
RESI conference and Digital medicine connect at Biopharm America
Christine Charette, SVP Strategic Finance, OBIO offers her perspective on the RESI conference and BioPharm America.
For a PDF of the full article, click here
Beyond Novelty: Adopting & Diffusing Innovation in the Supply Chain
Health Science Insider™ (OBIO Strategic Review: July 2016)
2016 has already been a productive year for OBIO as we push forward on our advocacy efforts, expand our Health Science networks and partnerships and continue to provide access to capital for Ontario Health Science companies in order for them to reach the next level.
Gail Garland, CEO
OBIO
For the full strategic review, click here
OBIO® Report Featured in Media Planet's Industry and Business Magazine
The article titled "From Opportunities To ROI – Adopting Innovation In Canada" focusses on the key recommendations of the OBIO report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy.”
Click here for the full article
OBIO® Report: Canadian health industry competitive but doesn't stand out
OBIO is a not-for-profit organization committed to the development of an integrated health innovation economy for the province. Its report, How Canada Should be Engaging in a $9 Trillion Dollar Health Economy, was based on surveys and interviews with 125 CEOs of health science companies around the country. It makes recommendations aimed to ensure Canadians get the economic and patient benefits from being competitive in the global health market.